Andrea D. Praticò

Off-Label Use of Drugs and Adverse Drug Reactions in Pediatric Units: A Prospective, Multicenter Study

Andrea D. Praticò, Laura Longo, Silvana Mansueto et al. · Current Drug Safety · 2018 · 89 citations

Pharmacy, Pediatrics, Pharmacology +17

In vitro efficacy of ARQ 092, an allosteric AKT inhibitor, on primary fibroblast cells derived from patients with PIK3CA-related overgrowth spectrum (PROS)

Carlotta Ranieri, Silvia Di Tommaso, Daria Carmela Loconte et al. · Neurogenetics · 2018 · 83 citations · Full text

Medicine, Molecular Medicine, Oncology +15

Early Immunotherapy and Longer Corticosteroid Treatment Are Associated With Lower Risk of Relapsing Disease Course in Pediatric MOGAD

Margherita Nosadini, Michael Eyre, Thea Giacomini et al. · Neurology Neuroimmunology & Neuroinflammation · 2022 · 68 citations · Full text

Medicine, Neurology, Pediatrics +16

A mosaic pattern of INI1/SMARCB1 protein expression distinguishes Schwannomatosis and NF2-associated peripheral schwannomas from solitary peripheral schwannomas and NF2-associated vestibular schwannomas

Rosario Caltabiano, Gaetano Magro, Agata Polizzi et al. · Child s Nervous System · 2017 · 66 citations

Medicine, Neuroscience, Oncology +12

Introduction to phacomatoses (neurocutaneous disorders) in childhood

Martino Ruggieri, Agata Polizzi, Gioacchino P. Marceca et al. · Child s Nervous System · 2020 · 59 citations

Medicine, Child Health, Pediatrics +9